Biotech And Ip News

Beam Therapeutics Sues Chinese Rivals Over Alleged Theft of Base Editing Secrets

Beam Therapeutics has filed a lawsuit in Massachusetts against YolTech Therapeutics and Serapha Bio, alleging that former employee Zi Jun 'Emma' Wang stole proprietary base editing data to develop a competing therapy for alpha-1 antitrypsin deficiency. The suit claims Wang accessed confidential records off-hours while employed by Beam, leading to the creation of a rival drug candidate that targets the same genetic mutation as Beam's lead program. Serapha Bio has denied the allegations, while YolTech has not responded.